Stockholders’ Equity (Tables)
|
6 Months Ended |
Jun. 30, 2023 |
|---|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
| Schedule of Share Based Payments Award Stock Options Valuation Assumptions |
The
fair value of stock-based awards was estimated using the Black-Scholes model with the following weighted average assumptions for the
six months ended June 30, 2023, and 2022:
Schedule of Share Based Payments Award Stock
Options Valuation Assumptions
| |
|
2023 |
|
|
2022 |
|
| Dividend
yield |
|
|
0.00 |
% |
|
|
0.00 |
% |
| Risk-free
interest rate |
|
|
4.05 |
% |
|
|
0.95-1.65 |
% |
| Expected
volatility |
|
|
100.23-100.25 |
% |
|
|
106.4-110.0
|
% |
| Expected
life (in years) |
|
|
5 |
|
|
|
5 |
|
|
| Schedule of Stock Option Activity |
Option
activity for the six months ended June 30, 2023 and the year ended December 31, 2022 was as follows:
Schedule
of Share Based Compensation Stock Option Activity
| |
|
Options |
|
|
Weighted
Average
Exercise
Price ($) |
|
|
Weighted
Average
Remaining
Contractual
Life (Yrs.) |
|
|
Aggregate
Intrinsic
Value ($) |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Options
outstanding at December 31, 2021 |
|
|
1,395,882 |
|
|
|
4.24 |
|
|
|
3.89 |
|
|
|
- |
|
| Granted |
|
|
487,473 |
|
|
|
2.50 |
|
|
|
4.43 |
|
|
|
- |
|
| Exercised |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Forfeited
or cancelled |
|
|
(84,302 |
) |
|
|
4.39 |
|
|
|
- |
|
|
|
- |
|
| Options
outstanding at December 31, 2022 |
|
|
1,799,053 |
|
|
|
3.76 |
|
|
|
3.30 |
|
|
|
- |
|
| Granted |
|
|
433,665 |
|
|
|
0.58 |
|
|
|
4.58 |
|
|
|
- |
|
| Exercised |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Forfeited
or cancelled |
|
|
(335,059 |
) |
|
|
3.60 |
|
|
|
- |
|
|
|
- |
|
| Options
outstanding at June 30, 2023 |
|
|
1,897,659 |
|
|
|
3.07 |
|
|
|
3.21 |
|
|
|
- |
|
| Options
expected to vest in the future as of June 30, 2023 |
|
|
409,974 |
|
|
|
1.93 |
|
|
|
4.03 |
|
|
|
- |
|
| Options
exercisable at June 30, 2023 |
|
|
1,487,685 |
|
|
|
3.38 |
|
|
|
2.98 |
|
|
|
- |
|
| Options
vested, exercisable, and options expected to vest at June 30, 2023 |
|
|
1,897,659 |
|
|
|
3.07 |
|
|
|
3.21 |
|
|
|
- |
|
|
| Schedule of Warranty Activity |
Warrant
activity for the six months ended June 30, 2023 and the year ended December 31, 2022 was as follows:
Schedule
of Warranty Activity
| |
|
Warrants |
|
|
Weighted
Average
Exercise
Price ($) |
|
|
Weighted
Average
Remaining
Contractual
Life (Yrs.) |
|
| Warrants
outstanding at December 31, 2021 |
|
|
3,987,931 |
|
|
|
6.10 |
|
|
|
2.10 |
|
| Granted |
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Exercised |
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Forfeited
or cancelled |
|
|
(164,652 |
) |
|
|
- |
|
|
|
- |
|
| Warrants
outstanding at December 31, 2022 |
|
|
3,823,279 |
|
|
|
4.66 |
|
|
|
1.19 |
|
| Granted |
|
|
1,490,896 |
|
|
|
0.58 |
|
|
|
2.62 |
|
| Exercised |
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Forfeited
or cancelled |
|
|
(2,412,086 |
) |
|
|
4.54 |
|
|
|
- |
|
| Warrants
outstanding at June 30, 2023 |
|
|
2,902,089 |
|
|
|
2.08 |
|
|
|
2.34 |
|
|
| Stock Appreciation Rights [Member] |
|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
| Schedule of Share Based Payments Award Stock Options Valuation Assumptions |
The
fair value of SAR awards was estimated using the Black-Scholes model with the following weighted average assumptions for the six months
ended June 30, 2023 and the year ended December 31, 2022:
Schedule
of Share Based Payments Award Stock Options Valuation Assumptions
| |
|
2023 |
|
|
2022 |
|
| Dividend
yield |
|
|
- |
|
|
|
0.00 |
% |
| Risk-free
interest rate |
|
|
- |
|
|
|
0.82-2.79 |
% |
| Expected
volatility |
|
|
- |
|
|
|
108.0-119.0 |
% |
| Expected
life (in years) |
|
|
- |
|
|
|
5 |
|
|
| Schedule of Stock Option Activity |
SARs
activity for the six months ended June 30, 2023 and the year ended December 31, 2022 was as follows:
Schedule
of Stock Option Activity
| |
|
SARs |
|
|
Weighted
Average
Exercise
Price ($) |
|
|
Weighted
Average
Remaining
Contractual
Life (Yrs.) |
|
|
Aggregate
Intrinsic
Value ($) |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| SARs
outstanding at December 31, 2021 |
|
|
370,624 |
|
|
|
3.15 |
|
|
|
4.24 |
|
|
|
- |
|
| Granted |
|
|
814,862 |
|
|
|
1.81 |
|
|
|
4.48 |
|
|
|
- |
|
| Exercised |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Forfeited
or cancelled |
|
|
(27,699 |
) |
|
|
2.91 |
|
|
|
- |
|
|
|
- |
|
| SARs
outstanding at December 31, 2022 |
|
|
1,157,787 |
|
|
|
2.21 |
|
|
|
4.11 |
|
|
|
- |
|
| Granted |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Exercised |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Forfeited
or cancelled |
|
|
(328,822 |
) |
|
|
2.10 |
|
|
|
- |
|
|
|
- |
|
| SARs
outstanding June 30, 2023 |
|
|
828,965 |
|
|
|
2.26 |
|
|
|
3.63 |
|
|
|
- |
|
| SARs
expected to vest in the future as of June 30, 2023 |
|
|
530,678 |
|
|
|
2.02 |
|
|
|
3.85 |
|
|
|
- |
|
| SARs
exercisable at June 30, 2023 |
|
|
298,287 |
|
|
|
2.68 |
|
|
|
3.24 |
|
|
|
- |
|
| SARs
vested, and exercisable, and SARs expected to vest at June 30, 2023 |
|
|
828,965 |
|
|
|
2.26 |
|
|
|
3.63 |
|
|
|
- |
|
|